IRF5 polymorphisms have been connected to elevated production of pro-inflammatory cytokines and type I interferons in Sjögren’s syndrome, which has been implicated in the development of systemic characteristics and an elevated risk of lymphoma. Here, IRF5 is linked to Sjogren syndrome.